Skip to main content

Eugit Therapeutics

San Carlos, United States

Eugit Therapeutics is a biotechnology research company that develops tissue targetting drugs for therapeutic purposes.

$500K raised
Sep 2022
Pre-Seed

Top Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Eugit Therapeutics

How much funding has Eugit Therapeutics raised?
Eugit Therapeutics has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2022.
Who are Eugit Therapeutics's investors?
Eugit Therapeutics's investors include Y Combinator.
Where is Eugit Therapeutics headquartered?
Eugit Therapeutics is headquartered in San Carlos, United States.
What does Eugit Therapeutics do?
Eugit Therapeutics is a biotechnology research company that develops tissue targetting drugs for therapeutic purposes.
What stage is Eugit Therapeutics at?
Eugit Therapeutics is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Eugit Therapeutics — Funding & Investors." VCBacked, September 8, 2022, https://www.vcbacked.co/company/eugit-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). Eugit Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/eugit-therapeutics
Wikipedia (cite web)
{{cite web |title=Eugit Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/eugit-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .